By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences today announced Michael Hunkapiller is replacing Hugh Martin as the company's president and CEO, effective immediately.

Martin will remain on the company's board of directors through its next annual meeting of shareholders and has agreed to resign from the board on the date of the meeting. He will serve as a consultant to PacBio for six months, it said in a document filed with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.